Newsroom der German Breast Group
In unserem Newsroom finden Sie Aktuelles rund um die German Breast Group.
-
30.08.2021 August 2021: Utility of the CPS + EG scoring system in TNBC patients treated with neoadjuvant chemotherapy
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer
-
19.07.2021 July 2021: Clinical and molecular characteristics of HER2-low-positive breast cancer
We are pleased to inform you that a pooled analysis of patients with HER2-low-positive breast cancer has been published in The Lancet Oncology
-
30.06.2021 June 2021: Chemotherapy-induced ovarian failure in young women with early breast cancer
A prospective analysis on chemotherapy-induced ovarian failure in young women with early breast cancer has been published in European Journal of Cancer
-
15.06.2021 Update-Seminar Klinische Pharmazie im September
Veranstaltungsempfehlung: 12. Klinische Pharmazie-Update-Seminar, 10. und 11. September 2021, Wiesbaden
-
01.06.2021 May 2021: Therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer
-
21.05.2021 GBG research at ASCO Virtual Meeting
We are happy to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ASCO Annual Meeting 2021, which will take place from 4 to 8 June.
-
23.04.2021 Please participate in the TILs-Survey
The International Immuno-Oncology Biomarker Working Group has launched a global survey on the potential use of Tumor Infiltrating Lymphocytes (TILs) for future trial designs and use in daily practice.
-
20.04.2021 GBG Research at ESMO Breast Cancer Virtual Meeting 2021
We are delighted to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ESMO Breast Cancer Virtual Meeting 2021, which will take place from 5 to 8 May 2021.
-
13.04.2021 April 2021: First results of the randomized phase III PenelopeB trial
We are delighted to inform you that the first results of the randomized phase III PenelopeB trial have been published on a Rapid Communications basis in Journal of Clinical Oncology.
